Our Programs

Using genomics to identify therapeutic options for patients with advanced solid or blood cancer of any type and to manage cancer risk.

Molecular Screening & Therapeutics (MoST) study

We are using the power of genomic technology to characterise molecular changes in a patient’s cancer that may help to identify a targeted therapy.

Read More

Genetic Cancer Risk in the Young (RisC) study

Understanding the genetic variants that contribute to inherited cancer.

Read More

Surveillance study in Multi-Organ Cancer prone syndromes (SMOC+)

Investigating and evaluating the surveillance practices used for people at high risk of multi-organ cancer.

Read More